We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.7B
AUM Growth
+$129M
Cap. Flow
-$29.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
38.9%
Holding
1,194
New
46
Increased
298
Reduced
730
Closed
120

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$37.6M
2
AVGO icon
Broadcom
AVGO
+$3.78M
3
EXAS
Exact Sciences
EXAS
+$3.05M
4
BKNG icon
Booking.com
BKNG
+$2.84M
5
NEE icon
NextEra Energy
NEE
+$2.62M

Sector Composition

Rank Sector Weight
1 Technology 47.26%
2 Healthcare 11.3%
3 Consumer Discretionary 9.84%
4 Communication Services 9.16%
5 Financials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTCT icon
451
PTC Therapeutics
PTCT
$6.37B
$592K 0.02%
19,358
-26,787
-58% -$868K
PAYC icon
452
Paycom
PAYC
$6.78B
$589K 0.02%
+4,121
New +$707K
ACGL icon
453
Arch Capital
ACGL
$36.1B
$586K 0.02%
5,806
-75
-1% -$7.29K
TTE icon
454
TotalEnergies
TTE
$193B
$584K 0.02%
8,755
-2,768
-24% -$197K
A icon
455
Agilent Technologies
A
$39.1B
$577K 0.02%
4,454
-28
-0.6% -$3.92K
GSK icon
456
GSK
GSK
$103B
$577K 0.02%
14,979
+433
+3% +$18.2K
MSCI icon
457
MSCI
MSCI
$40B
$577K 0.02%
1,197
-26
-2% -$12.9K
RYTM icon
458
Rhythm Pharmaceuticals
RYTM
$7B
$574K 0.02%
13,975
-20,306
-59% -$811K
BCS icon
459
Barclays
BCS
$94.1B
$573K 0.02%
53,500
+1,553
+3% +$16.1K
APA icon
460
APA Corp
APA
$12.8B
$573K 0.02%
19,457
+1,973
+11% +$61.1K
OMC icon
461
Omnicom Group
OMC
$22.7B
$571K 0.02%
6,371
+915
+17% +$85K
ACLS icon
462
Axcelis
ACLS
$4.12B
$569K 0.02%
4,003
+137
+4% +$15.8K
P
463
Everpure Inc
P
$24.8B
$569K 0.02%
8,863
-2,890
-25% -$167K
TSCO icon
464
Tractor Supply
TSCO
$16.3B
$568K 0.02%
10,515
-2,190
-17% -$118K
COR icon
465
Cencora
COR
$60.3B
$567K 0.02%
2,518
-15
-0.6% -$3.47K
CORT icon
466
Corcept Therapeutics
CORT
$10.2B
$563K 0.02%
17,321
-6,260
-27% -$171K
RXRX icon
467
Recursion Pharmaceuticals
RXRX
$1.57B
$561K 0.02%
74,771
-52,385
-41% -$457K
ING icon
468
ING
ING
$93.8B
$560K 0.02%
32,684
+959
+3% +$16.3K
CSL icon
469
Carlisle Companies
CSL
$13.6B
$558K 0.02%
1,377
-548
-28% -$221K
HPE icon
470
Hewlett Packard
HPE
$63.2B
$557K 0.02%
26,293
+1,649
+7% +$30.4K
BTI icon
471
British American Tobacco
BTI
$132B
$554K 0.02%
17,896
+517
+3% +$15.7K
AXSM icon
472
Axsome Therapeutics
AXSM
$12.4B
$553K 0.02%
6,871
-2,144
-24% -$159K
APGE icon
473
Apogee Therapeutics
APGE
$10.2B
$551K 0.02%
14,010
+3,090
+28% +$150K
EQNR icon
474
Equinor
EQNR
$95.9B
$550K 0.02%
19,260
+559
+3% +$15.6K
NTAP icon
475
NetApp
NTAP
$32.9B
$547K 0.02%
4,247
+271
+7% +$30.4K

Similar funds

Profund Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Profund Advisors held 1,194 positions worth $2.7B, up 5% from $2.57B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Profund Advisors's Q2 2024 filing shows 46 new, 298 increased, 730 reduced and 120 closed positions. Its largest new stake was HubSpot: 3,324 shares worth $1.96M. The largest sale was Apple, an estimated $22.4M.

By sector, the portfolio is most concentrated in Technology at 47% of assets, up from 43% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Profund Advisors's largest Q2 2024 buy was HubSpot: 3,324 shares worth $1.96M.
  • Profund Advisors added most to NVIDIA in Q2 2024, an estimated $37.6M increase.
  • Profund Advisors's biggest Q2 2024 reduction was Apple, cutting an estimated $22.4M.
  • Profund Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $3.01M.
  • Profund Advisors's ten largest holdings make up 39% of its $2.7B portfolio in Q2 2024.
  • Profund Advisors opened 46 new positions and closed 120 in Q2 2024.
  • Profund Advisors's portfolio value rose 5% quarter-over-quarter to $2.7B.

Based on Profund Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.